Screener
Vertex Pharmaceuticals VRTX Raw materials
Raw materials at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.
The source filing: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000875320-26-000173
FAQ
- What is Vertex Pharmaceuticals's raw materials?
- Vertex Pharmaceuticals (VRTX) reported raw materials of $267.4M in Q1 2026.
- How has Vertex Pharmaceuticals's raw materials changed year-over-year?
- Vertex Pharmaceuticals's raw materials increased by 6.7% year-over-year, from $250.5M to $267.4M.
- What is the long-term trend for Vertex Pharmaceuticals's raw materials?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's raw materials has grown at a 41.2% compound annual growth rate (CAGR), from $46.23M to $259.8M.
- What does raw materials mean?
- Unprocessed materials and components purchased for use in manufacturing, valued at cost.
Ask your AI about Vertex Pharmaceuticals's raw materials.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude